Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan

References

• Weaver AL. The impact of new biologicals in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2004;43 Suppl 3: iii17–23.
   Google Scholar
• Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Emery P, et al. Updated consensus statement on biological agents, for the treatment of rheumatic diseases, 2006. Ann Rheum Dis 2006;65 Suppl 3:iii2–15.
   Google Scholar
• Albers JM, Paimela L, Kurki P, Eberhardt KB, Emery P, van't Hof MA, et al. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis. Ann Rheum Dis 2001;60(5):453–8.
   Google Scholar
• van Aken J, Lard LR, le Cessie S, Hazes JM, Breedveld FC, Huizinga TW. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004;63(3):274–9.
   PubMed Web of Science ®Google Scholar
• Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefi t of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004;43(7):906–14.
   PubMed Web of Science ®Google Scholar
• Puolakka K, Kautiainen H, Mottonen T, Hannonen P, Korpela M, Hakala M, et al. FIN-RACo Trial Group. Early suppression of disease activity is essential for maintenance of work capacity in pa - tients with recent-onset rheumatoid arthritis: fi ve-year experience from the FIN-RACo trial. Arthritis Rheum 2005;52(1): 36–41.
   Google Scholar
• van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, et al. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 2006;29 54(4):1063–74.
   Google Scholar
• Porter DR, Capell HA, McInnes I, Munro R, Madhok R, Hunter JA, et al. Is rheumatoid arthritis becoming a milder disease? Or are we starting second-line therapy in patients with milder disease? Br J Rheumatol 1996;35(12):1305–8.
   PubMedGoogle Scholar
• Krishnan E, Fries JF. Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998: a longitudinal study of 3035 patients. Am J Med 2003;115(5):371–6.
   PubMed Web of Science ®Google Scholar
• Sokka T, Kautiainen H, Hakkinen A, Hannonen P. Radiographic progression is getting milder in patients with early rheumatoid arthritis: results of 3 cohorts over 5 years. J Rheumatol 2004; 31(6):1073–82.
   PubMed Web of Science ®Google Scholar
• Welsing PM, Fransen J, van Riel PL. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum 2005;52(9):2616–24.
   Google Scholar
• Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have signifi cantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005;52(4):1009–19.
   Google Scholar
• Finckh A, Choi HK, Wolfe F. Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved therapy. Ann Rheum Dis 2006 Mar 15 [Epub ahead of print].
   Google Scholar
• Matsuda Y, Singh G, Yamanaka H, Tanaka E, Urano W, Taniguchi A, et al. Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3763 patients with rheumatoid arthritis. Arthritis Rheum 2003;49(6):784–8.
   PubMed Web of Science ®Google Scholar
• Tanaka E, Saito A, Kamitsuji S, Yamada T, Nakajima A, Taniguchi A, et al. Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set. Arthritis Rheum 2005;53(6): 864–71.
   PubMed Web of Science ®Google Scholar
• Yamanaka H, Tohma S. Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice. Mod Rheumatol 2006;16(2):75–6.
   PubMedGoogle Scholar
• Kajiyama H, Akama H, Yamanaka H, Shoji A, Matsuda Y, Tanaka E, et al. One third of Japanese patients with rheumatoid arthritis use complementary and alternative medicine. Mod Rheumatol 2006;16(6):355–9.
   PubMedGoogle Scholar
• Furuya T, Kotake S, Inoue E, Nanke Y, Yago T, Kobashigawa T, et al. Risk factors associated with incident clinical vertebral and nonvertebral fractures in Japanese women with rheumatoid arthritis: a prospective 54-month observational study. J Rheumatol 2007;34(2):303–10.
   PubMed Web of Science ®Google Scholar
• Tanaka E, Singh G, Saito A, Syouji A, Yamada T, Urano W, et al. Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in Japan. Mod Rheumatol 2005;15(5):340–5.
   PubMedGoogle Scholar
• Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of DAS28-ESR and DAS28-CRP threshold values. Ann Rheum Dis 2007;66(3):407–9.
   Google Scholar
• Yamada T, Nakajima A, Inoue E, Tanaka E, Hara M, Tomatsu T, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis 2006;65(12):1661–3.
   PubMed Web of Science ®Google Scholar
• Nakajima A, Kamitsuji S, Saito A, Tanaka E, Nishimura K, Horikawa N, et al. Disability and patient's appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan. Mod Rheumatol 2006;16(3):151–7.
   PubMedGoogle Scholar
• Ikari K, Momohara S, Inoue E, Tomatsu T, Hara M, Yamanaka H, et al. Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology (Oxford). 2006;45(11):1345–8.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classifi cation of rheumatoid arthritis. Arthritis Rheum 1988;31(3):315–24.
   PubMed Web of Science ®Google Scholar
• Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score DAS28 with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004;43(10):1252–5.
   Google Scholar
• Miyasaka N, Takeuchi T, Eguchi K. Guidelines for the proper use of etanercept in Japan. Mod Rheumatol 2006;16(2):63–7.
   Google Scholar
• Pincus T, Yazici Y, Sokka T, Aletaha D, Smolen JS. Methotrexate as the �anchor drug� for the treatment of early rheumatoid arthritis. Clin Exp Rheumatol 2003;21;5 Suppl 31:S179–85.
   Google Scholar
• Symmons D, Tricker K, Harrison M, Roberts C, Davis M, Dawes P, et al. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensifi ed treatment with traditional disease modifying anti-rheumatic drugs-results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) 2006;45(5):558–65.
   PubMed Web of Science ®Google Scholar